PHI — Phase Holographic Imaging PHI AB Share News
0.000.00%
- SEK33.42m
- SEK22.75m
- SEK16.65m
Brief: PHI Says Resolves On Fully Secured Rights Issue Of Shares Of Aprox SEK 64.3 Million
Brief: Phase Holographic Imaging Phi AB Says AGM Resolved, In Accordance With Board's Proposal, That No Dividend Shall Be Paid For Fiscal Year Of 2022/23
Brief: PHI Receives Second Loan Commitment Of SEK 20 Mln
Brief: Phase Holographic Gets SEK 18 Mln Through Share Options
Brief: PHI And Supplier Of Cell Analysis Instrumentation Sign Agreement
Brief: Phase Holographic Imaging: Life Science Tools Co Enters Technology Assessment Agreement
Brief: Phase Holographic Imaging Q2 EBITDA Loss Widens To SEK 4.6 Mln
Brief: Phase Holographic Imaging Phi AB Q1 EBITDA Loss Widens To SEK 3.1 Million
Brief: PHI Receives SEK 46.3 Million Through Rights Issue
Marketing Agreement
Marketing Agreement
Brief: Phase Holographic Imaging To Conduct Rights Issue Of Units
Brief: PHI Q4 2017/18 Net Sales Up At SEK 2.2 Million
Brief: Phase Holographic To Expand Collaboration With USCF
Brief: Phase Holographic Imaging Q2 Operating Loss Widens To SEK 3.3 Million
Brief: Phase Holographic Imaging Q4 net sales SEK 1.2 million
Brief: Phase Holographic Imaging PHI delivers HoloMonitor to Australian research institute
Brief: Phase Holographic Imaging and Malmö University receives SEK 2.3 mln to detect blood-borne cancer cells
Brief: Phase Holographic: Japan's medical institute purchases multiple HoloMonitor instruments